STRATEGIC MARKETING INNOVATIONS

Lobbying for CARDINAL POINT PARTNERS, LLC ON BEHALF OF TONIX PHARMACEUTICALS · Federal relations firm

Filing Registration

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · posted Apr 21, 2025

Lobbying activity 3

Disaster Planning/Emergencies

Funding for biodefense and pandemic preparedness medical countermeasures Patient access to novel non-opioid analgesics

Defense

Funding for biodefense and pandemic preparedness medical countermeasures Patient access to novel non-opioid analgesics

Health Issues

Funding for biodefense and pandemic preparedness medical countermeasures Patient access to novel non-opioid analgesics

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.